Anthony Cheung
Fondatore presso ENGENE HOLDINGS INC.
Patrimonio netto: 970 092 $ in data 30/06/2024
Profilo
Anthony T.
Cheung is the founder of enGene Holdings, Inc. (founded in 2023) and currently holds the title of Chief Technology Officer.
Dr. Cheung is also the founder of enGene,.
Inc...
Dr. Cheung's education history includes an undergraduate degree from the University of British Columbia and a doctorate degree from Tulane University School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ENGENE HOLDINGS INC.
0.23% | 18/03/2024 | 102 873 ( 0.23% ) | 970 092 $ | 30/06/2024 |
Posizioni attive di Anthony Cheung
| Società | Posizione | Inizio |
|---|---|---|
| ENGENE HOLDINGS INC. | Fondatore | 24/04/2023 |
enGene, Inc.
 enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Fondatore | - |
Formazione di Anthony Cheung
| University of British Columbia | Undergraduate Degree |
| Tulane University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ENGENE HOLDINGS INC. | Health Technology |
| Aziende private | 1 |
|---|---|
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Health Technology |
- Borsa valori
- Insiders
- Anthony Cheung
